Nipocalimab Phase 3 Dose Selection for Severe Hemolytic Disease of the Fetus and Newborn.

Zhou J, Xiong Y, Lam E, Ling LE, Saeed-Khawaja S, Komatsu Y, Vermeulen A, Samtani MN, Leu JH

DOI: 10.1002/jcph.70259
Published: 2026 Sep
Container: Journal of clinical pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jcph.70259,
  title = {Nipocalimab Phase 3 Dose Selection for Severe Hemolytic Disease of the Fetus and Newborn.},
  author = {Zhou J and Xiong Y and Lam E and Ling LE and Saeed-Khawaja S and Komatsu Y and Vermeulen A and Samtani MN and Leu JH},
  year = {2026},
  journal = {Journal of clinical pharmacology},
  doi = {10.1002/jcph.70259},
  url = {https://doi.org/10.1002/jcph.70259}
}

RIS

TY  - JOUR
TI  - Nipocalimab Phase 3 Dose Selection for Severe Hemolytic Disease of the Fetus and Newborn.
AU  - Zhou J
AU  - Xiong Y
AU  - Lam E
AU  - Ling LE
AU  - Saeed-Khawaja S
AU  - Komatsu Y
AU  - Vermeulen A
AU  - Samtani MN
AU  - Leu JH
PY  - 2026
JO  - Journal of clinical pharmacology
DO  - 10.1002/jcph.70259
UR  - https://doi.org/10.1002/jcph.70259
ER  -

APA

J, Z., Y, X., E, L., LE, L., S, S., Y, K., A, V., MN, S., & JH, L. (2026). Nipocalimab Phase 3 Dose Selection for Severe Hemolytic Disease of the Fetus and Newborn.. Journal of clinical pharmacology. https://doi.org/10.1002/jcph.70259

Source records

pubmed · retrieved 2026-09-25T04:25:18.459Z